Reduction of bacterial infections in newly hatched chicks by the use of antimicrobial dips: Preliminary approaches

Summary

Bacteriological examination of hatchery waste eggs, identification of the isolated bacteria, and susceptibility testing against seven antimicrobial agents were used in an attempt to establish a rational basis for reducing bacterial infections in newly hatched chicks.

Chloramphenicol at 1000 ppm was selected as the antibiotic for preliminary dipping trials and 0.45% iodophore (Wescodyne) was added for later trials. The control treatment consisted of formaldehyde fumigation. The following conclusions can be drawn:

(1) Hatchery waste eggs are highly contaminated (69.1%) and enterobacteriaceae predominate (26.6%).

(2) Chloramphenicol is the most effective antimicrobial tested.

(3) Dip treatments with either chloramphenicol alone or chloramphenicol plus Wescodyne result in a reduced percentage of abnormal navels (8.4% and 10.4%), as compared with 21.9% for the control treatment.

(4) Hatchability of either group of dipped eggs is reduced in comparison with fumigated eggs.

(5) Dip treatment with chloramphenicol plus Wescodyne significantly reduces the anal carrier rates for Escherichia coli, Pseudomonas aeruginosa, Salmonella spp., and Staphylococcus aureus. This treatment reduces the incidence of bacterial infection in abnormal navels to zero.     

Treatment of cervical oesophageal rupture in horses

Oesophageal rupture in horses has only been previously described in detail in isolated case reports. The objectives of this study were to describe the clinical findings, specific treatment and outcome of oesophageal rupture in horses. Medical records of horses diagnosed with oesophageal rupture between 1994–2008 were reviewed. Clinical findings, treatment and outcome were recorded. Seven horses with cervical oesophageal perforations were included in the study. Two horses were subjected to euthanasia without treatment and 5 were treated surgically. Treatment involved a fasciotomy of the cervical musculature and oesophageal tube placement. Three of 5 horses survived long‐term (>one year). Our study showed that surgical treatment of cervical oesophageal rupture involving fasciotomy and oesophagostomy tube placement can be successful with 3/5 of treated horses surviving more than one year.     

EFFICACY AND TOXICITY OF AN ACCELERATED HYPOFRACTIONATED RADIATION THERAPY PROTOCOL IN CATS WITH ORAL SQUAMOUS CELL CARCINOMA

Squamous cell carcinoma (SCC) is the most common feline oral tumor. Standard radiation protocols have been reported to achieve tumor control durations of 1.5–5.5 months (45–165 days). The purpose of this study was to describe the efficacy and toxicity of an accelerated hypofractionated radiation therapy protocol in cats with oral SCC. Twenty‐one cats with histologically confirmed oral SCC and T1‐3N0M0 were treated with 10 once‐daily fractions (Monday–Friday) of 4.8 Gy. Seventeen cats had macroscopic disease and four were microscopic after incomplete excision. Acute toxicity consisted of grade 2 mucositis in all cats and this was effectively managed using esophageal or gastric tube feeding, pain medication, and antibiotics. Late toxicity effects for cats with available follow‐up data included alopecia (4 cats), leukotricia (6), tongue ulceration (1), and oronasal fistula (1). Response could be assessed in 17 cats (seven complete response and five partial response). Four cats (19%) developed metastatic disease without evidence of local progression. The median progression‐free survival (PFS) was 105 days (1 year PFS of 23%), median local progression‐free survival (LPFS) was 219 days (1 year LPFS of 41%), and median overall survival (OS) was 174 days (1 year OS of 29%). Only tumor stage was prognostic, with T1 having a median PFS of 590 days. Findings indicated that this accelerated hypofractionated radiation therapy protocol was well tolerated in cats with oral SCC, with manageable adverse events. Tumor response was observed in most cats and long tumor control durations were achieved in some cats.     

In vitro effect of levamisole on the cell viability,phagocytosis and respiratory burst of Barbel chub (Squaliobarbus curriculus) macrophages

The present study was to determine in vitro effect of levamisole on the immune functions of Barbel chub (Squaliobarbus curriculus), head–kidney‐derived (HKM), spleen‐derived (SM) and peripheral blood monocyte‐derived macrophage (PBM). Macrophages were incubated with levamisole 10³, 10¹, 10⁻¹ and 10⁻³ ng mL⁻¹ to assay the cell viability, respiratory burst and phagocytosis. The results showed that macrophages treated with levamisole 10⁻³ ng mL⁻¹ gave a maximum respiratory burst response, whereas levamisole 10³ ng mL⁻¹ had no effect. Phagocytosis activity of the macrophages treated with levamisole enhanced significantly when compared to control, maximum response being at 10⁻³ ng mL⁻¹. While using the methylthiazoletetrazolium method to measure the cell activity for 12, 24, 36, 48, 60 h, there was no significant role on proliferation and the cell viability began to decline after 24 h. In conclusion, levamisole is a potent enhancer of Barbel chub macrophage activity with low concentration.     

Theoretical and Empirical Relationships Between Oat Test Weight and Groat Proportion

Test weight and groat proportion are two very important quality characteristics of oat grain. In this study, we pose the hypothesis that these two characteristics are related through characteristics of grain density. Test weight is defined as the product of kernel density and packing proportion. Groat proportion, in theory, is the ratio of the groat mass to the kernel mass. We present two theoretical constructions expressing test weight in terms of groat proportion, packing proportion and kernel density components. To test these, we have applied measurements of test weight, groat proportion, kernel density components, and packing proportion of 18 oat cultivars grown at six environments. Whereas the groat proportion alone accounted for only 34% of the variation in test weight, our theoretical constructions that included groat proportion could account for ≤82% of variation in test weight. Also, we present previously undescribed variation in oat kernel density components across genotypes and environments. Although the kernel density alone could account for most of the variation in test weight across genotypes, packing proportion appeared to be more important in describing variation in test weight of a genotype across different environments. We observed significant variation in both groat and hull density which, together with groat proportion, described most of the variation in kernel density.     

Staying current by searching the veterinary literature

The body of knowledge in veterinary medicine and the biomedical sciences continues to grow logarithmically, and learning about new developments in veterinary medicine requires successful navigation of recently published literature worldwide. This article examines how veterinarians can use different types of automated services from databases and publishers to search the current and past literature, access articles, and manage references that are found.     

In this issue – June 2009

Bandaging and second intention healing in distal limbs of horses  ▪  Auricular chondrosis in a horse  ▪  National survey of antimicrobials in the Australian pig industry  ▪  Analgesia for knife and ring castration in lambs  ▪  Incidence of lymphoma in a colony of baboons  ▪  Viruses in black tiger prawns from Weipa  ▪  Sacral osteochondrosis in German Shepherd Dogs  ▪  Congenital pyloric obstruction from a gastric hyperplastic polyp     

Evaluation of a multi‐agent chemotherapy protocol combining dexamethasone,melphalan, actinomycin D,and cytarabine for the treatment of resistant canine non‐Hodgkin high‐grade lymphomas: a single centre's experience

The DMAC protocol (dexamethasone, melphalan, actinomycin‐D, cytarabine) has been evaluated in American studies for the treatment of relapsed canine lymphoma, comparing similarly to other rescue protocols. The aim of this study was to evaluate efficacy and toxicity of DMAC, in a larger UK cohort of resistant canine lymphomas. Medical records of dogs with resistant non‐Hodgkin high‐grade lymphomas that received DMAC as a rescue protocol were reviewed from 2007 to 2017. Response, time from initiation to discontinuation (TTD) and toxicity (Veterinary Cooperative Oncology Group criteria) were assessed. One hundred dogs were included; 86 received CEOP (modified CHOP including epirubicin) as first‐line treatment. Thirty‐five dogs (35%) responded: 21 complete responders (CRs) and 14 partial responders (PRs). Responders had significantly longer TTD (P < 0.001) compared with non‐responders: 62 days (range 28‐952) for CR vs 32 days (range 20‐70) for PR. Six CR received more than six cycles of DMAC (range 7‐36 cycles) and experienced a longer TTD (median 508, range 126‐952 days). Thrombocytopenia occurred in 45% (24 grade 1‐2, 21 grade 3‐4) and neutropenia in 36% of cases (29 grade 1‐2, 7 grade 3‐4). Gastrointestinal toxicity occurred in 42% of dogs (40 grade 1‐2, 2 grade 3‐4). Owing to chemotherapy toxicity, treatment was discontinued in five, and hospitalization required in six cases. In this study, response to DMAC was lower and of generally shorter duration than previously reported. Toxicity was high, but infrequently led to hospitalization or discontinuation of treatment.